Autobahn Therapeutics
PrivateLast Round
Series C
Jul 24, 2024
Total Funding Raised
$208.7M
Company Overview
Autobahn Therapeutics is a biotechnology company developing regenerative medicines and brain-targeting chemistry aimed at treating central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autobahn Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Autobahn Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 24, 2024 | ||||
| Series B Extension | Sep 8, 2022 | ||||
| Series B | Jun 9, 2020 |
Autobahn Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series C |
| S32 | Series B Extension, Series C, Series B |
| ARCH Venture Partners | Series C |
| TD Securities | Series B Extension, Series B |
| Blue Owl Capital | Series B Extension, Series C, Series B |
| Monograph Capital | Series C |
| Invus Opportunities | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2025
Will present at Evercore's Emerging Private Biotech Conference.
- Jul 24, 2024
$100M round completed.
Autobahn Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Autobahn Therapeutics's valuation, stock price, and market status.